Panel recommends new, better shingles shot over old version

A federal panel recommended Wednesday that older people already vaccinated for shingles get a new, better shot.

The advisory group said the just-approved vaccine made by GlaxoSmithKline works better at preventing shingles and may last longer than the one that's been sold in the U.S. since 2006.

Shingles, a painful condition that causes blisters, occurs when the chickenpox virus resurfaces decades later, often when people are in their 60s or older. About 1 in 3 U.S. residents will get it during their lifetime, according to the Centers for Disease Control and Prevention.

At a meeting in Atlanta, the Advisory Committee on Immunization Practices said doctors should...